{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:52:39Z","timestamp":1791924759862,"version":"4.3.4"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,6,25]]},"DOI":"10.1001\/jama.2019.8145","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T17:36:19Z","timestamp":1561484179000},"page":"2414","source":"Crossref","is-referenced-by-count":819,"title":["Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI"],"prefix":"10.1001","volume":"321","author":[{"given":"Hirotoshi","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Domei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital, Kitakyusyu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Natsuaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University, Saga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shiomi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Toyota","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Ohya","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Suwa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Nanasato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Minamino Cardiovascular Hospital, Hachioji, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sendai Cardiovascular Center, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Suematsu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Yokomatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Takamisawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute, Fuchu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kagawa Prefectural Central Hospital, Takamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gifu Prefectural General Medical Center, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Okayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ehime Prefectural Central Hospital, Matsuyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitane","family":"Seino","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hoshi General Hospital, Koriyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shizuoka General Hospital, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shizuoka General Hospital, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chikamori Hospital, Kochi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nakao","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital, Kitakyusyu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ikari","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokai University Hospital, Isehara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi Igarashi","family":"Hanaoka","sequence":"additional","affiliation":[{"name":"Hanaoka Seishu Memorial Cardiovascular Clinic, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Morino","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Iwate Medical University Hospital, Morioka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Kadota","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the STOPDAPT-2 Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"joi190060r1","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery.","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"joi190060r2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"issue":"9985","key":"joi190060r3","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"joi190060r4","doi-asserted-by":"publisher","first-page":"e0174502","DOI":"10.1371\/journal.pone.0174502","article-title":"Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: a comparison between the DAPT study and 9 other trials evaluating DAPT duration.","volume":"12","author":"Toyota","year":"2017","journal-title":"PLoS One"},{"issue":"23","key":"joi190060r5","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"joi190060r6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.","volume":"125","author":"R\u00e4ber","year":"2012","journal-title":"Circulation"},{"issue":"8934","key":"joi190060r7","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"Lancet"},{"issue":"15","key":"joi190060r8","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes.","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"issue":"19","key":"joi190060r9","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/CIRCULATIONAHA.117.032615","article-title":"High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): a randomized superiority trial.","volume":"137","author":"Taguchi","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"joi190060r10","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jacc.2015.06.1323","article-title":"Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention.","volume":"66","author":"G\u00e9n\u00e9reux","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"joi190060r11","first-page":"804","article-title":"Trade-off of myocardial infarction vs bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.","volume":"38","author":"Valgimigli","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"joi190060r12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12928-015-0366-9","article-title":"One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent (STOPDAPT) trial.","volume":"31","author":"Natsuaki","year":"2016","journal-title":"Cardiovasc Interv Ther"},{"issue":"20","key":"joi190060r13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"joi190060r14","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.jcin.2015.03.029","article-title":"Acute thrombogenicity of a durable polymer everolimus-eluting stent relative to contemporary drug-eluting stents with biodegradable polymer coatings assessed ex vivo in a swine shunt model.","volume":"8","author":"Otsuka","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"joi190060r15","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"joi190060r16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.112.104059","article-title":"Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET).","volume":"126","author":"Kimura","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"joi190060r17","first-page":"219","article-title":"The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease.","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"issue":"23","key":"joi190060r18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting.","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"issue":"17","key":"joi190060r19","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.","volume":"334","author":"Sch\u00f6mig","year":"1996","journal-title":"N Engl J Med"},{"issue":"9038","key":"joi190060r20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"8","key":"joi190060r21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41569-018-0049-1","article-title":"Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention.","volume":"15","author":"Capodanno","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"joi190060r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in Myocardial Infarction (TIMI) trial\u2014phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"joi190060r23","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"joi190060r24","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"joi190060r25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.","volume":"329","author":"GUSTO investigators","year":"1993","journal-title":"N Engl J Med"},{"issue":"10","key":"joi190060r26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"issue":"18","key":"joi190060r27","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1100452","article-title":"Randomized trial of stents versus bypass surgery for left main coronary artery disease.","volume":"364","author":"Park","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"joi190060r28","doi-asserted-by":"publisher","first-page":"e008708","DOI":"10.1161\/JAHA.118.008708","article-title":"Prediction of thrombotic and bleeding events after percutaneous coronary intervention: CREDO-Kyoto thrombotic and bleeding risk scores.","volume":"7","author":"Natsuaki","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"joi190060r29","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.jacc.2016.02.064","article-title":"Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS.","volume":"67","author":"Baber","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"joi190060r30","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk.","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"issue":"10151","key":"joi190060r31","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","article-title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.","volume":"392","author":"Vranckx","year":"2018","journal-title":"Lancet"},{"issue":"19","key":"joi190060r32","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction.","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"joi190060r33","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease.","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"24","key":"joi190060r34","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document.","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"issue":"14","key":"joi190060r35","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease.","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"joi190060r36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4244\/EIJY14M06_09","article-title":"Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: a patient-level data analysis of the Bern-Rotterdam and j-Cypher registries.","volume":"11","author":"Onuma","year":"2015","journal-title":"EuroIntervention"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jama\/article-pdf\/321\/24\/2414\/17671789\/jama_watanabe_2019_oi_190060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T17:36:21Z","timestamp":1561484181000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2019.8145"}},"subtitle":["The STOPDAPT-2 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":36,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,6,25]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.8145","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736041963.793568613","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,25]]}}}